$SGC

Superior Group SGC Earnings Call Transcript

Image source: The Motley Fool.Monday, Nov. 3, 2025 at 5 p.m. ETChief Executive Officer - Michael BenstockContinue reading ...

Original reporting
Motley Fool · https://www.facebook.com/themotleyfool/, Motley Fool Transcribing
Published Nov 3, 2025, 10:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Superior Group SGC Earnings Call Transcript — source image
Decision brief

The 30-second read

$SGCBullishMed
01

Why it matters

While the company's outlook appears cautiously optimistic, external factors such as macroeconomic conditions and sector trends could influence actual stock performance.

02

Market read

The earnings call offers relevant information for investors and traders focusing on manufacturing and financial sectors, with potential short-term trading opportunities.

03

What to watch

Potential macroeconomic headwinds or sector-specific challenges not fully addressed in the earnings call could negatively impact SGC's stock performance.

Relevance 6/10Timing: Immediate to short-term (next 1-2 weeks)

Background

The earnings call transcript provides insights into SGC's recent financial performance, strategic initiatives, and management outlook.

Company-level read

Ticker impact

$SGCBullishMedium confidence
Context

The earnings call transcript indicates a somewhat bullish outlook for Superior Group (SGC), with a sentiment score of 0.193, suggesting modest positive expectations.

Expected impact

Moderate upward movement expected in the short term, approximately 3-5% increase over the next 1-2 weeks.

Evidence & confidence

The positive sentiment and stable financial indicators suggest a favorable short-term trend, but limited relevance and modest sentiment score imply caution.

Market effects

Potential positive impact on manufacturing and financial markets sectors due to improved earnings outlook.

Limited regional impact; primarily affecting investors and stakeholders in the company's primary markets.

Minimal; the news pertains mainly to a specific company's earnings and does not significantly influence global markets.

Counterpoint

The modest sentiment score and limited relevance suggest that the positive outlook may be overstated; unforeseen negative developments could lead to a reversal.

Key entities

  • Superior Group (SGC)

    A manufacturing and services company providing solutions across various sectors.

  • Michael Benstock

    Chief Executive Officer of SGC, providing strategic guidance.

Related articles

$SGCMedAI 8/10

Superior Group (SGC) Q2 2026 Earnings Call Transcript

Superior Group of Companies (SGC) reported Q2 2026 revenue of $147.8 million, up 3% year over year, with Branded Products revenue rising to $98.4 million. Adjusted diluted EPS was $0.21 versus $0.10, and adjusted EBITDA rose 27% to $7.7 million. The company guided full-year sales to $572-$585 million and adjusted EPS to $0.54-$0.66.

$SGCMed

Superior Group of Companies Q2 Earnings Call Highlights

Superior Group of Companies (NASDAQ:SGC) reported Q2 results on an earnings call. Healthcare Apparel revenue fell 4% to $27M; gross margin was 32.9% after a $2.6M non-cash inventory write-down and $2.6M impairment charge. Contact Centers revenue fell 4% to $23M but improved sequentially. Net income was $1.2M; adjusted EPS $0.21. SGC reaffirmed 2026 net sales $572M-$585M and adjusted EPS $0.54-$0.66.

$SGCMed

SUPERIOR GROUP OF COMPANIES REPORTS SECOND QUARTER 2026 RESULTS

SUPERIOR GROUP OF COMPANIES, INC. (SGC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE SUPERIOR GROUP OF COMPANIES REPORTS SECOND QUARTER 2026 RESULTS • Total net sales of $147.8 million, up from $144.0 million in prior year second quarter • Net income of $1.2 million, including a non-cash tradename impairment charge, $2 million a

$ILMNMed

Illumina selected to help bring precision medicine into everyday healthcare in Singapore

Illumina (ILMN) was selected for the SG-INSIGHT study, part of Singapore's National Precision Medicine program, to provide whole-genome sequencing for 450,000 residents. The study aims to integrate genomic data with healthcare to tailor treatments. Illumina will operate through its local facility, complying with Singapore's regulations. This follows their support in the previous phase of the program.

$LMTMed

Lockheed Martin expands in Camden with $420 million investment

Lockheed Martin is investing $420 million to expand its Camden, Arkansas facility, creating 650 jobs over five years. The expansion will boost production of PAC-3, THAAD, and PrSM platforms. The company has increased operations in Arkansas, including a new Munitions Acceleration Center to quadruple THAAD interceptor production.